Associated Papers
Characterization of a patient-derived variant of GPX4 for precision therapy.
Liu H et al.
Nature Chemical Biology, 2022
Development of therapies for rare genetic disorders of GPX4: roadmap and opportunities.
Cheff DM et al.
Orphanet Journal of Rare Diseases, 2021
Mutations in the enzyme glutathione peroxidase 4 cause Sedaghatian-type spondylometaphyseal dysplasia.
Smith AC et al.
Journal of Medical Genetics, 2014
Select a paper to view details